Company Overview of Ohr Pharmaceutical, Inc.
|Age||Total Calculated Compensation||This person is connected to 7 Board Members in 7 different organizations across 10 different industries.|
See Board Relationships
As of Fiscal Year 2015
Dr. Jason Scott Slakter, M.D., has been the Chief Executive Officer of Ohr Pharmaceutical, Inc. since September 2015. Dr. Slakter served as the Chief Medical Officer of Ohr Pharmaceutical, Inc. from May 2014 to August 7, 2015. He co-founded SKS Ocular, LLC in 2010 and served as its Chief Executive Officer. Dr. Slakter served as the Clinical Advisor of Acucela Inc. He served as Chief Medical Officer of Potentia Pharmaceuticals, Inc. He serves as an Editor-in-Chief of ...
800 Third AvenuePhone: 212-682-8452
New York, New York 10022
Board Members Memberships
Chief Executive Officer and Director
There is no Education data available.
|Total Annual Compensation||$200,000|
|Restricted Stock Awards||$163,333|
|Total Number of Options||$50,000|
|Total Annual Cash Compensation||$200,000|
|Total Short Term Compensation||$200,000|
|Other Long Term Compensation||$163,333|
|Total Calculated Compensation||$610,622|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries